Norges Bank
ONC

Norges Bank’s BeOne Medicines Ltd ONC Stock Holding History

Norges Bank’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,400
Closed -$4.74M – 1780
2025
Q1 		$4.74M Sell
17,400
-82,606
-83% -$19.3M ﹤0.01% 1374
2024
Q4 		$18.5M Sell
100,006
-6,351
-6% -$1.3M ﹤0.01% 1246
2024
Q3 		$23.9M Buy
+106,357
New +$19.1M ﹤0.01% 1192
2024
Q1 		– Sell
-27,477
Closed -$4.96M – 1975
2023
Q4 		$4.96M Sell
27,477
-26,523
-49% -$4.8M ﹤0.01% 1676
2023
Q3 		$9.71M Hold
54,000
– – ﹤0.01% 1489
2023
Q2 		$9.63M Hold
54,000
– – ﹤0.01% 1548
2023
Q1 		$11.6M Hold
54,000
– – ﹤0.01% 1518
2022
Q4 		$11.9M Hold
54,000
– – ﹤0.01% 1506
2022
Q3 		$7.28M Buy
+54,000
New +$9.27M ﹤0.01% 1642
2022
Q1 		– Sell
-346,341
Closed -$93.8M – 2244
2021
Q4 		$93.8M Hold
346,341
– – 0.02% 645
2021
Q3 		$126M Buy
346,341
+331,675
+2,262% +$108M 0.03% 540
2021
Q2 		$5.03M Buy
+14,666
New +$4.86M ﹤0.01% 1907
2020
Q1 		– Sell
-406,908
Closed -$67.4M – 2076
2019
Q4 		$67.4M Hold
406,908
– – 0.02% 726
2019
Q3 		$49.8M Hold
406,908
– – 0.02% 875
2019
Q2 		$50.4M Hold
406,908
– – 0.02% 875
2019
Q1 		$53.7M Buy
406,908
+66,122
+19% +$8.92M 0.02% 825
2018
Q4 		$47.8M Hold
340,786
– – 0.02% 774
2018
Q3 		$58.7M Hold
340,786
– – 0.02% 746
2018
Q2 		$52.4M Buy
340,786
+60,739
+22% +$10.8M 0.02% 793
2018
Q1 		$47M Buy
280,047
+172,535
+160% +$23.4M 0.02% 828
2017
Q4 		$10.5M Buy
107,512
+64,279
+149% +$5.88M ﹤0.01% 1720
2017
Q3 		$4.47M Buy
+43,233
New +$3.22M ﹤0.01% 1880
2017
Q1 		– Sell
-20,000
Closed -$607K – 2187
2016
Q4 		$607K Buy
+20,000
New +$629K ﹤0.01% 2107

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank's ONC Position: Q2 2025 in Review

Norges Bank sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 17,400 shares — an estimated $4.74M sold.

Norges Bank first reported a position in ONC in Q4 2016 and held it in 23 quarters. The position peaked at $126M in Q3 2021. 243 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Norges Bank reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Norges Bank sold 17,400 BeOne Medicines Ltd shares in Q2 2025, an estimated $4.74M.
  • Norges Bank first reported a position in BeOne Medicines Ltd in Q4 2016 and held it in 23 quarters.
  • Norges Bank's BeOne Medicines Ltd position peaked at $126M in Q3 2021.
  • 243 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Norges Bank's 13F filing for Q2 2025, filed 13 Aug 2025.